Invicro (United States)

Recent papers from Invicro (United States)

1. A revised visual grading scale of the cavum septi pellucidi in contact-collision sport athletes with repetitive head impactsCommunications Medicine · 2026
2. A pilot study of the vitamin status of the population of the Russian Federation based on the results of research conducted in a network of clinical diagnostic laboratoriesRussian Journal of Preventive Medicine · 2026
3. [18F]MNI-1054, a novel PET ligand for lysine-specific histone demethylase 1 A (LSD1): first-in human validation and enzyme occupancy of the LSD1 inhibitor TAK-418EJNMMI Research · 2026
4. The PET tracer [ ¹¹ C]MODAG-005 targets alpha-synuclein aggregates in the brainScience Translational Medicine · 2026
5. Evaluation of [18F]MNI-1054, a novel PET ligand for lysine-specific histone demethylase 1A (LSD1), in non-human primatesEJNMMI Research · 2025
6. [11C]MODAG 005 – a PET tracer targeting alpha-synuclein aggregates in the brain2025
7. Evaluation of Mitochondrial Complex 1 Density with [¹⁸F]BCPP-EF in a Murine Model and Individuals with Friedreich AtaxiaJournal of Nuclear Medicine · 2025
8. A pharmacovigilance study of adverse events associated with polycythemia vera treatments using the FDA Adverse Event Reporting System (FAERS) databaseAnnals of Hematology · 2025
9. GABA A receptor availability in clinical high-risk and first-episode psychosis: a [ 11 C]Ro15-4513 positron emission tomography study2025
10. PET imaging of an antisense oligonucleotide in the living non-human primate brain using click chemistry2025
11. Quantifying VMAT2 target occupancy at effective valbenazine doses and comparing to a novel VMAT2 inhibitor: a translational PET studyNeuropsychopharmacology · 2025
12. LRRK2 -associated parkinsonism with and without in vivo evidence of alpha-synuclein aggregates: longitudinal clinical and biomarker characterizationBrain Communications · 2025
13. The QIBA Profile for Dynamic Susceptibility Contrast MRI Quantitative Imaging Biomarkers for Assessing GliomasRadiology · 2024
14. Longitudinal imaging of therapeutic enzyme expression after gene therapy for Fabry disease using positron emission tomography and the radiotracer [18F]AGALMolecular Therapy · 2024
15. Clinical validation of an AI-based pathology tool for scoring of metabolic dysfunction-associated steatohepatitisNature Medicine · 2024
16. Cellular oxygen consumption in patients with diabetic ketoacidosisIntensive Care Medicine Experimental · 2024
17. Preclinical in vitro and in vivo evaluation of [ ¹¹ C]ORM-13070 as PET ligand for alpha-2C adrenergic receptor occupancy using PET imaging in non-human primatesJournal of Cerebral Blood Flow & Metabolism · 2024
18. Kinetic Analysis and Metabolism of Poly(Adenosine Diphosphate–Ribose) Polymerase-1–Targeted18F-Fluorthanatrace PET in Breast CancerJournal of Nuclear Medicine · 2024
19. Prediction, prognosis and monitoring of neurodegeneration at biobank-scale via machine learning and imaging2024
20. Discovery and clinical translation of ceperognastat, an O‐GlcNAcase (OGA) inhibitor, for the treatment of Alzheimer's diseaseSHILAP Revista de lepidopterología · 2024